A Utah House committee unanimously approved a bill to study the effects of hormone therapy and other medical treatments prescribed for a gender transition on transgender minors.
The measure, sponsored by Rep. Brad Daw (R-Orem), instructs the Utah Department of Health to hire three experts in medicine or pharmacology to conduct a review of existing research on the diagnosis and treatment of youth suffering from gender dysphoria.
Daw had originally considered introducing a bill to ban hormone therapy and gender confirmation surgery for anyone under the age of 18 — similar to measures introduced in several other state legislatures this year.
But he decided instead to introduce a bill looking at the science behind gender-affirming care before moving forward with a ban on such treatments.
“After talking with a number of people and raising concerns, it appeared to me that we just don’t know [about the effects of hormone therapy],” Daw told the Utah Valley-based Daily Herald. “There’s a lot of information we don’t have. And so before we rush in and ban something completely, and maybe disrupt minors who are going through the treatment, which probably would be very problematic, let’s gather information.”
Daw said he had “grave concerns” about hormones lie Lupron, which he says can potentially cause sterility and blindness. He previously stated that youth should not be allowed to make potentially life-altering decisions that they may regret later in life.
Various opponents and supporters of the bill testified at the hearing, with conservatives — including the conservative advocacy group Eagle Forum of Utah — supporting the bill, while transgender advocates were more skeptical of its intentions.
Utah resident Erin Brewer, who identifies as a “former trans kid,” spoke in favor of the bill, saying she was diagnosed with gender dysphoria after being sexually assaulted as a child, while her brother was spared any abuse.
She said a psychologist helped her understand that she was using her gender identity to cope with the trauma stemming from the assault.
“In my child’s mind, I thought that being a boy would prevent me from ever being hurt that way again,” Brewer said. “If I had been medically transitioned, I never would have understood that the hatred that I had for my female body was the result of being violently violated. I never would have realized that my transgender identity was in fact a coping mechanism.”
But Hayley McLoughlin, the parent of a 16-year-old transgender boy, credited puberty blockers with saving her son’s life, saying it allowed her son to talk to a therapist and deal with his feelings of gender dysphoria so that he could decide whether he wanted to transition.
Candice Metzler, the director of Transgender Education Advocates of Utah, criticized the bill as being a political statement, rather than a measure that genuinely intends to help transgender or questioning youth.
She has previously noted that there is an abundance of medical information, all readily accessible, that lawmakers could avail themselves of if they were serious about investigating the medications used to transition.
She added that, if lawmakers really want to assist transgender or gender-nonconforming children, they could fund anti-bullying initiatives or pass legislation to make schools more inclusive.
“I’m not necessarily for or against [the bill], but I’m for putting resources towards things that are going to actually help this population instead of politicizing it,” she said.
The U.S. House of Representatives voted largely along party lines to advance a bill that would imprison doctors for providing gender-affirming care to transgender minors and punish parents who consent to their child’s treatment.
The bill, introduced by U.S. Rep. Marjorie Taylor Greene (R-Ga.), would impose prison sentences of up to 10 years on medical providers who recommend or prescribe puberty blockers, hormone therapy, or surgery to transgender patients under 18. It would also criminalize parents who consent to their child’s treatment or transport them across state lines to obtain such care.
The Trump administration has proposed two federal rules that would restrict access to gender-affirming care for transgender minors nationwide.
The proposed regulations, issued by the U.S. Department of Health and Human Services' Centers for Medicare and Medicaid Services (CMS), would bar federal Medicaid funds from covering transition-related care for transgender youth under 19 and threaten to strip federal funding from hospitals that provide gender-affirming treatments to minors.
HHS officials told NBC News that CMS will begin the federal rule-making process with a 60-day public comment period, after which the rules could be finalized.
A recent study of injectable pre-exposure prophylaxis found that twice-yearly injections of lenacapavir -- marketed as Yeztugo by Gilead Sciences -- do not have clinically significant interactions with gender-affirming hormone therapy.
"In the most gender-diverse Phase III PrEP trial conducted to date, lenacapavir had no clinically significant impact on feminizing or masculinizing gender-affirming therapy concentrations," the study’s researchers concluded, as reported by POZ.
The study, led by Dr. Jill Blumenthal of the University of California San Diego, examined whether lenacapavir interacts with gender-affirming hormone therapy, including estradiol (a form of estrogen) and testosterone. Because those hormones are metabolized by enzymes such as CYP3A4 -- which lenacapavir can inhibit -- the researchers analyzed whether the drug altered hormone levels.
These are challenging times for news organizations. And yet it’s crucial we stay active and provide vital resources and information to both our local readers and the world. So won’t you please take a moment and consider supporting Metro Weekly with a membership? For as little as $5 a month, you can help ensure Metro Weekly magazine and MetroWeekly.com remain free, viable resources as we provide the best, most diverse, culturally-resonant LGBTQ coverage in both the D.C. region and around the world. Memberships come with exclusive perks and discounts, your own personal digital delivery of each week’s magazine (and an archive), access to our Member's Lounge when it launches this fall, and exclusive members-only items like Metro Weekly Membership Mugs and Tote Bags! Check out all our membership levels here and please join us today!
You must be logged in to post a comment.